Enhanced transgene expression in quiescent and activated human CD8 + T cells

Human Gene Therapy

Volumn 15, Issue 7, 2004, Pages 648-658

  Cooper, Laurence J N ^a   Topp, Max S ^b,c   Pinzon, Cris ^b   Plavec, Ivan ^d   Jensen, Michael C ^a   Riddell, Stanley R ^b   Greenberg, Philip D ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d BioSeek Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BETA INTERFERON; GREEN FLUORESCENT PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; PHOSPHOGLYCERATE KINASE; RETROVIRUS VECTOR;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MAMMAL CELL; MOLONEY LEUKEMIA ONCOVIRUS; NUCLEOTIDE SEQUENCE; REPORTER GENE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENE;

CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DRUG RESISTANCE; GENE EXPRESSION; GENETIC VECTORS; GENTAMICINS; GREEN FLUORESCENT PROTEINS; HUMANS; INTERFERON-BETA; LYMPHOCYTE ACTIVATION; MATRIX ATTACHMENT REGIONS; MOLONEY MURINE LEUKEMIA VIRUS; PROMOTER REGIONS (GENETICS); TERMINAL REPEAT SEQUENCES; TRANSGENES;

MAMMALIA; MOLONEY MURINE LEUKEMIA VIRUS; ONCOVIRINAE; UNIDENTIFIED RETROVIRUS;

EID: 3142707099     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/1043034041361217     Document Type: Article

References (34)

1. AGARWAL, M., AUSTIN, T.W., MOREL, F., CHEN, J., BOHNLEIN, E., and PLAVEC, I. (1998). Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J. Virol. 72, 3720-3728.
2. ANDREATTA, C., NAHREINI, P., HOVLAND, A.R., KUMAR, B., EDWARDS-PRASAD, J., and PRASAD, K.N. (2001). Use of short-lived green fluorescent protein for the detection of proteasome inhibition. Biotechniques 30, 656-660.
3. BANKER, D.E., GROUDINE, M., WILLMAN, C.L., NORWOOD, T., and APPELBAUM, F.R. (1998a). Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents. Leuk. Res. 22, 221-239.
4. BANKER, D.E., RADICH, J., BECKER, A., KERKOF, K., NORWOOD, T., WILLMAN, C., and APPELBAUM, F.R. (1998b). The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults. Clin. Cancer Res. 4, 3051-3062.
5. BARTZ, S.R., and VODICKA, M.A. (1997). Production of high-liter human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12, 337-342.
6. BODE, J., and MAASS, K. (1988). Chromatin domain surrounding the human interferon-β gene as defined by scaffold-attached regions. Biochemistry 27, 4706-4711.
7. BODE, J., KOHWI, Y., DICKINSON, L., JOH, T., KLEHR, D., MIELKE, C., and KOHWI-SHIGEMATSU, T. (1992). Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 255, 195-197.
8. BOULIKAS, T. (1993). Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J. Cell. Biochem. 52, 14-22.
9. COOPER, L.J., KALOS, M., LEWINSOHN, D.A., RIDDELL, S.R., and GREENBERG, P.D. (2000). Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J. Virol. 74, 8207-8212.
10. CORISH, P., and TYLER-SMITH, C. (1999). Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng. 12, 1035-1040.
11. DANG, Q., AUTEN, J., and PLAVEC, I. (2000). Human β-interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector. J. Virol. 74, 2671-2678.
12. DUCH, M., PALUDAN, K., LOVMAND, J., PEDERSEN, L., JORGENSEN, P., and PEDERSEN, F.S. (1993). A correlation between dexamethasone inducibility and basal expression levels of retroviral vector proviruses. Nucleic Acids Res. 21, 4777-4782.
13. DUCH, M., PALUDAN, K., JORGENSEN, P., and PEDERSEN, F.S. (1994). Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses. J. Virol. 68, 5596-5601.
14. + T cells. J. Immunol. 166, 6530-6536.
15. FORRESTER, W.C., FERNANDEZ, L.A., and GROSSCHEDL, R. (1999). Nuclear matrix attachment regions antagonize methylation dependent repression of long-range enhancer-promoter interactions. Genes Dev. 13, 3003-3014.
16. GARCIA, J.V., and MILLER, A.D. (1994). Retrovirus vector-mediated transfer of functional HIV-1 regulatory genes. AIDS Res. Hum. Retroviruses 10, 47-52.
17. GARRIDO, S.M., WILLMAN, C., APPELBAUM, F.R., and BANKER, D.E. (2000). Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples. Cytometry 42, 83-94.
18. GERASIMOVA, T.I., and CORCES, V.G. (2001). Chromatin insulators and boundaries: Effects on transcription and nuclear organization. Annu. Rev. Genet. 35, 193-208.
19. GLAZKO, G.V., KOONIN, E.V., ROGOZIN, I.B., and SHABALINA, S.A. (2003). A significant fraction of conserved noncoding DNA in human and mouse consists of predicted matrix attachment regions. Trends Genet. 19, 119-124.
20. HORN, P.A., TOPP, M.S., MORRIS, J.C., RIDDELL, S.R., and KIEM, H.P. (2002). Highly efficient gene transfer into baboon marrow re-populating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells. Blood 100, 3960-3967.
21. JENUWEIN, T., FORRESTER, W.C., FERNANDEZ-HERRERO, L.A., LAIBLE, G., DULL, M., and GROSSCHEDL, R. (1997). Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 385, 269-272.
22. KALOS, M., and FOURNIER, R.E. (1995). Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain. Mol. Cell. Biol. 15, 198-207.
23. KINSELLA, T.M., and NOLAN, G.P. (1996). Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7, 1405-1413.
24. KLEHR, D., MAASS, K., and BODE, J. (1991). Scaffold-attached regions from the human interferon β domain can be used to enhance the stable expression of genes under the control of various promoters. Biochemistry 30, 1264-1270.
25. LI, X., ZHAO, X., FANG, Y., JIANG, X., DUONG, T., FAN, C., HUANG, C.C., and KAIN, S.R. (1998). Generation of destabilized green fluorescent protein as a transcription reporter. J. Biol. Chem. 273, 34970-34975.
26. MIELKE, C., MAASS, K., TUMMLER, M., and BODE, J. (1996). Anatomy of highly expressing chromosomal sites targeted by retroviral vectors. Biochemistry 35, 2239-2252.
27. MILLER, A.D., MILLER, D.G.. GARCIA, J.V., and LYNCH, C.M. (1993). Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217, 581-599.
28. MILLER, D.G., EDWARDS, R.H., and MILLER, A.D. (1994). Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 91, 78-82.
29. RIDDELL, S.R., and GREENBERG, P.D. (1990). The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Methods 128, 189-201.
30. SCHORPP, M., JAGER, R., SCHELLANDER, K., SCHENKEL, J., WAGNER, E.F., WEIHER, H., and ANGEL, P. (1996). The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res. 24, 1787-1788.
31. SCHUBELER, D., MIELKE, C., MAASS, K., and BODE, J. (1996). Scaffold/matrix-attached regions act upon transcription in a context-dependent manner. Biochemistry 35, 11160-11169.
32. VIEIRA, J., and MESSING, J. (1991). New pUC-derived cloning vectors with different selectable markers and DNA replication origins. Gene 100, 189-194.
33. YANG, T.T., CHENG, L., and KAIN, S.R. (1996). Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res. 24, 4592-4593.
34. ZHANG, G., GURTU, V., and KAIN, S.R. (1996). An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem. Biophys. Res. Commun. 227, 707-711.